On June 7, 2018, the USPTO issued a memorandum to the Examining Corps providing patent eligibility examination guidance based on the recent Federal Circuit decision in Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals. The Vanda memo emphasizes that method of treatment claims can be found to satisfy 35 USC § 101 at the first step of an Alice/Mayo … Continue reading this entry